These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37633820)

  • 1. Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 - Results from the German KORA-Age study.
    Schluessel S; Huemer MT; Peters A; Drey M; Thorand B
    Obes Res Clin Pract; 2023; 17(4):349-352. PubMed ID: 37633820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.
    Scott D; Blyth F; Naganathan V; Le Couteur DG; Handelsman DJ; Waite LM; Hirani V
    Clin Nutr; 2023 Sep; 42(9):1610-1618. PubMed ID: 37481869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery.
    Vieira FT; Godziuk K; Lamarca F; Melendez-Araújo MS; Lima RM; Prado CM; de Carvalho KMB; Dutra ES
    Clin Nutr; 2022 Sep; 41(9):1932-1941. PubMed ID: 35947895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenic obesity defined by the ESPEN and EASO consensus statement in older women: Risk of falls and bone mineral density implications.
    Montalvão-Sousa TM; Ferreira PA; Colombelli NL; de Carvalho KMB; Blazevich AJ; Lima RM
    Arch Gerontol Geriatr; 2024 Sep; 124():105444. PubMed ID: 38643667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation.
    Shimizu A; Maeda K; Ueshima J; Inoue T; Murotani K; Ohno T; Nomoto A; Nagano A; Kayashita J; Mori N; Fujishima I
    Mech Ageing Dev; 2022 Dec; 208():111728. PubMed ID: 36084796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of the Diagnostic Criteria for Sarcopenic Obesity Defined by ESPEN/EASO Criteria in Acutely Admitted Patients with Stroke: Prevalence and Association with Outcomes.
    Abe T; Yoshimura Y; Sato Y; Nagano F; Matsumoto A
    J Nutr Sci Vitaminol (Tokyo); 2023; 69(6):454-462. PubMed ID: 38171818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.
    Donini LM; Busetto L; Bischoff SC; Cederholm T; Ballesteros-Pomar MD; Batsis JA; Bauer JM; Boirie Y; Cruz-Jentoft AJ; Dicker D; Frara S; Frühbeck G; Genton L; Gepner Y; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Nyulasi I; Parrinello E; Poggiogalle E; Prado CM; Salvador J; Rolland Y; Santini F; Serlie MJ; Shi H; Sieber CC; Siervo M; Vettor R; Villareal DT; Volkert D; Yu J; Zamboni M; Barazzoni R
    Clin Nutr; 2022 Apr; 41(4):990-1000. PubMed ID: 35227529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.
    Donini LM; Busetto L; Bischoff SC; Cederholm T; Ballesteros-Pomar MD; Batsis JA; Bauer JM; Boirie Y; Cruz-Jentoft AJ; Dicker D; Frara S; Frühbeck G; Genton L; Gepner Y; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Nyulasi I; Parrinello E; Poggiogalle E; Prado CM; Salvador J; Rolland Y; Santini F; Serlie MJ; Shi H; Sieber CC; Siervo M; Vettor R; Villareal DT; Volkert D; Yu J; Zamboni M; Barazzoni R
    Obes Facts; 2022; 15(3):321-335. PubMed ID: 35196654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer.
    Zhou J; Luo L; Xie L; Hu S; Tan L; Lei X; Luo X; Yang M
    Clin Nutr; 2023 Jun; 42(6):817-824. PubMed ID: 37084468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Applicability of the ESPEN and EASO-Defined Diagnostic Criteria for Sarcopenic Obesity in Japanese Patients after Stroke: Prevalence and Association with Outcomes.
    Yoshimura Y; Wakabayashi H; Nagano F; Matsumoto A; Shimazu S; Shiraishi A; Kido Y; Bise T
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic agreement of sarcopenic obesity with different definitions in Chinese community-dwelling middle-aged and older adults.
    Hu F; Zhang G; Xu Z; Zuo Z; Huang N; Ge M; Liu X; Dong B
    Front Public Health; 2024; 12():1356878. PubMed ID: 38903580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific bioelectrical vectors pattern in individuals with sarcopenic obesity.
    Marini E; Sulis S; Vorobel'ová L; Stagi S
    Clin Nutr; 2024 Mar; 43(3):620-628. PubMed ID: 38306890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic obesity and falls in older adults: A validation study of ESPEN/EASO criteria and modifications in Western China communities.
    Li R; Chen X; Tang H; Luo S; Lian R; Zhang W; Zhang X; Hu X; Yang M
    Arch Gerontol Geriatr; 2024 Dec; 127():105557. PubMed ID: 38964054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review.
    Donini LM; Busetto L; Bauer JM; Bischoff S; Boirie Y; Cederholm T; Cruz-Jentoft AJ; Dicker D; Frühbeck G; Giustina A; Gonzalez MC; Han HS; Heymsfield SB; Higashiguchi T; Laviano A; Lenzi A; Parrinello E; Poggiogalle E; Prado CM; Rodriguez JS; Rolland Y; Santini F; Siervo M; Tecilazich F; Vettor R; Yu J; Zamboni M; Barazzoni R
    Clin Nutr; 2020 Aug; 39(8):2368-2388. PubMed ID: 31813698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of EASO/ESPEN-Defined Sarcopenic Obesity Following a Technology-Based Weight Loss Intervention.
    Wood BS; Batchek DJ; Lynch DH; Spangler HB; Gross DC; Petersen CL; Batsis JA
    Calcif Tissue Int; 2024 Jan; 114(1):60-73. PubMed ID: 37758867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
    Lee J; Hong YP; Shin HJ; Lee W
    J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study.
    Huang S; Li J; Chen M; Zhu T; Lei X; Li Q; Yang Q; Chen X
    Clin Nutr ESPEN; 2024 Apr; 60():343-347. PubMed ID: 38479933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a new definition of sarcopenic obesity in middle-aged and older adults and association with cognitive function: Findings from the National Health and Nutrition Examination Survey 1999-2002.
    Booranasuksakul U; Tsintzas K; Macdonald I; Stephan BC; Siervo M
    Clin Nutr ESPEN; 2024 Oct; 63():919-928. PubMed ID: 39181532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
    Gortan Cappellari G; Semolic A; Zanetti M; Vinci P; Ius M; Guarnieri G; Busetto L; Donini LM; Barazzoni R
    Metabolism; 2023 Aug; 145():155595. PubMed ID: 37245728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenic Obesity and Outcomes for Patients With Cancer.
    Liu C; Liu T; Deng L; Zhang Q; Song M; Shi J; Liu C; Xie H; Chen Y; Lin S; Zheng X; Zhang H; Barazzoni R; Shi H
    JAMA Netw Open; 2024 Jun; 7(6):e2417115. PubMed ID: 38874924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.